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Abstract: - Pseudomonas aeruginosa biofilms are commonly implicated in nosocomial infections, yet the relevance of its clinical 
testing is poorly addressed. The study therefore aims to determine the knowledge, attitudes, and practices of physicians 
(dermatologists, infectious disease specialists, otolaryngologists, pulmonologists, reconstructive specialists, and urologists) in public 
and private tertiary hospitals in the National Capital Region on the clinical relevance of P. aeruginosa biofilm detection. The study 
employed a descriptive correlational research design that involved an online survey. The questionnaire utilized was adapted and 
modified from the study of Swanson et al. (2017) and She et al. (2015) and was subjected to pilot testing. Data was gathered though 
distribution of Google forms in social media and academic platforms and through e-mail while observing ethical considerations. 
Data was analyzed descriptively and statistically using SPSS version 25.0 software. Analysis of responses from 56 physicians 
revealed good knowledge (6.30 out of 8.00) on P. aeruginosa biofilms, neutral attitude (2.57 out of 5.00) towards the clinical 
application of biofilm detection, and moderate practice (1.77 out of 4.00) in the diagnosis and management of P. aeruginosa biofilm-
associated infections. Attitude towards clinical utility was positive, but overall attitude was neutral due to anticipated obstacles for 
adaptation. Meanwhile, practices are moderate due to the unavailability of a standard method for biofilm detection. No statistically 
significant correlation among knowledge, attitude, and practice was found. Further studies are recommended to designate a definitive 
method for clinical use and to explore knowledge, attitude, and practices using widened inclusion criteria and standardized survey 
tools.   
Key Words: — Pseudomonas aeruginosa, Biofilm, Pseudomonas aeruginosa biofilm, Biofilm detection, KAP.
I. INTRODUCTION 
Uncontrolled emergence of nosocomial infection or hospital-
acquired infection (HAI) is a very unenviable adverse event in 
the provision of healthcare. HAIs contribute to overall patient 
and healthcare burden by exacerbating the patient condition, 
thereby prolonging hospital stay and doubling the patient and  
healthcare cost [1]. In the Philippines, HAI is acknowledged as 
a major public health concern especially in government-owned 
hospitals with poor maintenance [2].  
 
Centers for Disease Control & Prevention (CDC) recorded in 
their “Antibiotic Resistance Threats Report 2019” that the 
multidrug resistant P. aeruginosa is one of the commonly 
isolated pathogens from hospitalized patients. P. aeruginosa 
bacteria remain as a leading cause of nosocomial infections due 
to its notable virulence factors such as biofilm formation, which 
strengthen its infectivity [3]. Biofilms are adaptive mechanisms 
that allow bacteria to become more resistant to various 
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environments and extreme conditions such as exposure to 
antibacterial agents. Biofilm-enclosed P. aeruginosa can 
spread infections including sinusitis, periodontitis, middle ear 
infections, osteomyelitis, urinary tract infections, chronic lung 
infections in patients with cystic fibrosis, and device-related 
biofilm diseases. Alongside, it can also escalate antibiotic 
resistance in the hospital setting [4]. HAIs caused by biofilm-
producing organisms such as P. aeruginosa are becoming more 
prevalent [5].  Detection of biofilm-associated infections (BAI) 
is therefore critically important to give the best course of 
treatment to patients, avoid chronic complications, and to 
prevent BAI outbreaks within facilities.  
 
There is a wide variation in the methods to detect biofilm, but a 
standard test has not yet been established [6]. The lack of 
routine biofilm testing hinders opportunities in the 
improvement of overall healthcare and the application of 
biofilm detection tests in the clinical setting. In the Philippines, 
biofilm detection methods are not performed in clinical 
laboratories. This study therefore aims to investigate the 
knowledge, attitudes, and practices (KAP) of physicians in 
tertiary hospitals of National Capital Region (NCR) in the 
Philippines to determine the clinical relevance and impart the 
importance of biofilm detection in healthcare system. Analysis 
of results were made to determine if educational interventions 
are imperative to raise awareness regarding the significance of 
biofilm detection, especially of that of P. aeruginosa, in the 
Philippine hospital setting. 
II. FRAMEWORK 
  A. Theoretical Framework 
 
Health belief model by Kabiru et al. [7] was adapted and 
modified because of its usefulness in serving as a guide for the 
determination of the KAP of physicians on the clinical 
application of P. aeruginosa biofilm detection in the hospital 
setting. Figure 1 shows the modified health belief model 
applied to biofilm detection. 
The modified health belief model illustrates that the physicians’ 
likelihood to engage in a particular health behavior, which in 
this case is recommending P. aeruginosa biofilm detection, is 
influenced by the following variables: sociodemographic 
variables of the physicians and their knowledge on P. 
aeruginosa biofilm-associated infections; 
 
 
Fig.1. Health Belief Model Applied to Biofilm Detection 
Perceived benefits of P. aeruginosa biofilm detection; 
perceived barriers to P. aeruginosa biofilm detection; perceived 
susceptibility of patients to P. aeruginosa biofilm-associated 
infections; perceived severity of P. aeruginosa biofilm-
associated infections; and perceived threat of P. aeruginosa 
biofilm-associated infections due to ineffective antibiotic 
treatment, untreatable illness of patients, and prevalence of P. 
aeruginosa biofilm-associated infections. 
 
  B. Conceptual Framework  
 
The KAP model seen in Figure 2 was adapted from Kwol et al. 
[8] for the conceptual framework of the study. It depicts that 
acquiring knowledge about P. aeruginosa biofilm would 
influence the attitude of the physician regarding P. aeruginosa 
biofilm detection. Likewise, the change in attitude would also 
lead to changes in practice of P. aeruginosa biofilm detection 
and managing P. aeruginosa BAI. Consequently, both the 
changes in attitude and practice of the physicians would result 




Fig.2. Paradigm of the Study 
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  A. Research Design 
 
Descriptive correlational research design was used in the study. 
An online survey was conducted to gather information 
regarding the KAP of physicians on P. aeruginosa biofilm and 
to determine whether educational interventions will be 
necessary with the intention to spread awareness regarding the 
matter. This study correlated the relationship between the 
extent of KAP of the physicians regarding biofilm, P. 
aeruginosa biofilm, and methods to detect P. aeruginosa 
biofilm. 
 
  B. Sampling Design 
 
Purposive sampling was employed wherein physicians of select 
medical specialties relevant to P. aeruginosa biofilm infections 
were included. Convenience sampling was also used by 
circulating online the invitations to participate and 
accommodating all eligible respondents available. Due to the 
limitation brought by the increasing COVID-19 cases in the 
hospitals and the lack of information regarding the population 
of medical specialists, the sample size was not calculated. 
Instead, the total number of respondents who participated in the 
data gathering was considered as the sample size. 
 
  C. Research Locale and Respondents 
 
The study was conducted from January to May 2021. The 
inclusion criteria for the respondents in the study were licensed 
physicians specializing in infectious diseases, pulmonology, 
dermatology, reconstructive specialty, urology, or 
otolaryngology and practicing in licensed and accredited public 
and/or private tertiary hospitals in the National Capital Region 
of the Philippines.  
 
  D. Survey Questionnaire 
 
The questionnaire utilized was adapted from “Understanding 
biofilm in practice: a global survey of health professionals” by 
Swanson et al. [9] and “Survey of Physicians’ Perspectives and 
Knowledge about Diagnostic Tests for Bloodstream Infections” 
by She et al. [10]. It was then modified to align with the study’s 
objectives. Permission was asked from the respective authors 
regarding the adaptation of their questionnaires. 
The questionnaire utilized in this study had two versions— in 
English and Filipino language, with the latter validated by the 
Commission on the Filipino Language. Each version comprised 
four parts which aimed to obtain the following data: 1) 
sociodemographic of the respondents; 2) knowledge of 
respondents on biofilms produced by P. aeruginosa; 3) 
attitudes of respondents on the clinical application of P. 
aeruginosa biofilm detection; and 4) practices of respondents 
on the diagnosis of biofilm-associated P. aeruginosa infection. 
The survey questionnaire covered the following types of 
questions: sociodemographic questions, close-ended questions 
with true/false or Likert scale answer choices, and open-ended 
questions.  
 
The survey was assessed by conducting a pilot testing and using 
Cronbach alpha to check internal consistency before the online 
deployment of the survey.  
 
  E. Data Gathering Procedure 
 
Gathering of responses was initiated by posting the invitation 
containing the links for the online survey in various social 
media platforms such as Facebook, Twitter, Reddit, and 
Instagram; and in academic platforms such as ResearchGate 
and Academia.edu. Moreover, the e-mail addresses of 
physicians that met the inclusion criteria were obtained from 
their respective contact information as correspondent authors in 
online publications and medical associations such as the 
Philippine Association of Plastic Reconstructive and Aesthetic 
surgeons, Journal of the Philippine Dermatological Society, and 
the Philippine Journal of Otolaryngology-Head and Neck 
Surgery.  
 
Afterwards, the questionnaire was sent to the respondents via 
Google mail. The responses were further screened to make sure 
that the respondents met the inclusion criteria. 
 
Google Forms was utilized to conduct the survey. An informed 
consent was included in the survey, and each respondent had 
the freedom to choose their preferred language, either in 
English or Filipino, in answering the survey. It was assured that 
the gathering of data was conducted with ethical consideration.  
 
  F. Data Analysis 
 
The data underwent descriptive analysis and statistical analyses 
using International Business Machines Statistical Package for 
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the Social Sciences version 25.0 software. Frequency 
distribution was utilized for the sociodemographic profiling of 
the respondents. 
 
The respondents’ KAP was determined using KAP scoring of 8 
knowledge, 35 attitude, and 4 practice questions. Scores for 
knowledge questions range from 0 to 8 points. Each correct 
response was equivalent to ‘1’ point while wrong responses and 
“I do not know” responses were equivalent to ‘0’ point. Scores 
for attitude questions ranged from 0 to 35 points. Likert 
responses were given corresponding points ranging from 1 to 5, 
while reverse scoring was done for questions that were 
negatively phrased. Mean was computed for items A4–A6. 
Scoring for practice questions ranged from 0 to 4 points, 
wherein ‘1’ point was given for every “Yes” responses while 
‘0’ point was given to “No” responses and “I do not know” 
responses. For P3, every response that indicated usage of 
laboratory methods was given ‘1’ point. Whereas zero point 
was given to responses which only used other studies or had 
“not applicable” or “none” responses.  
 
Overall level of KAP of the physicians was categorized using 
Modified Bloom’s cut-off point adapted from Seid and Hussen 
[11]. For the overall knowledge of the respondents, scores of 
80–100% (6–8 points) were classified as good knowledge; 50–
79% (4–5 points) as moderate knowledge; and less than 50% 
(0–3 points) as poor knowledge. For overall attitude, scores of 
80–100% (28–35 points) was classified as positive attitude; 50–
79% (18–27 points) as neutral attitude; and less than 50% (0–
17 points) as negative attitude. For practice, scores between 80–
100% (3-4 points) was classified as good practice; 50–79% (2 
points) as moderate practice; and less than 50% (0-1 point) as 
poor practice. Afterwards, ranking was done to determine the 
medical specialties with the highest KAP scores and to identify 
which medical specialty perceives biofilm detection of P. 
aeruginosa to be of highest clinical utility.  
 
To determine the extent of KAP of the physicians, each 
question was analyzed. Knowledge questions were ranked from 
1 to 8 in order of decreasing frequency and percentage of 
correct response. The average frequency and percentage of 
correct responses was obtained to determine the overall 
frequency and percentage of the respondents with correct 
response and good knowledge. Furthermore, the weighted 
mean of the responses per attitude question was calculated then 
categorized based on the following criteria: “positive” for 1–
2.49, “neutral” for 2.5–3.49, and “negative” for 3.5–5 points. 
Frequency distribution was utilized to present the responses 
categorized by topic to the single open-ended question in A8. 
Moreover, the percentage of every “Yes” response for every 
question and usage of laboratory test for P3 was determined. It 
was assessed using the following criteria: “poor” for 
percentages ranging from 0–59 %, “moderate” for 60-79%, 
“good” for 80-100%. Responses in P3 were categorized by 
topic and presented as frequency distribution. 
 
Pearson’s correlational analysis was performed to establish the 
presence or absence of a significant association between the 
respondent physicians’ KAP with a p <0.05 level of statistical 
significance (2-tailed). 
 
  G. Ethical Considerations 
 
The study was approved by the Faculty of Pharmacy-Research 
Ethics Committee. There was no conflict of interest declared by 
the researchers. Privacy and confidentiality of the respondents’ 
names, personal information, and responses was also assured. 
Given that informed consent was included in the survey 
questionnaire, the respondents were made aware of the 
description of the study, benefits, risks, and ethical 
consideration. Participation in the study of the respondents was 
voluntary as the respondents have the right to withdraw at any 
point.  Risks for the respondents were minimal wherein no 
respondents were harmed. No monetary compensation was 
given to the participants. 
IV. RESULTS AND DISCUSSION 
  A. Sociodemographic Profile of Respondents 
 
Table.1. Sociodemographic Profile. 
 
Age-group (years) N % 
25–30 6 10.7 
31–35 13 23.2 
36–40 10 17.9 
41–45 7 12.5 
46–50 4 7.1 
51–55 7 12.5 
56–60 6 10.7 
61–65 2 3.6 
66–70 1 1.8 
Gender   
Male 22 39.3 
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Female 34 60.7 
Medical Specialization   
Infectious disease specialist 7 12.5 
Pulmonologist 5 8.9 
Dermatologist 12 21.4 
Reconstructive specialist 8 14.3 
Urologist 12 21.4 
Otolaryngologist 12 21.4 
Years in Medical Practice   
1-5 8 14.3 
6-10 11 19.6 
11-15 14 25.0 
16-20 7 12.5 
21-25 5 8.9 
26-30 4 7.1 
31-35 6 10.7 
36-40 1 1.8 
Classification of Hospital   
Public 18 32.1 
Private 23 41.1 
Public and Private 15 26.8 
Table 1 continued. 
Location of Hospital N % 
City of Las Piñas 1 1.8 
City of Makati 2 3.6 
City of Manila 17 30.4 
City of Muntinlupa 3 5.4 
City of Pasig 6 10.7 
City of Quezon 10 17.9 
City of Caloocan, City of Quezon, 
City of Valenzuela 
2 3.6 
City of Las Piñas, City of Makati, City 
of Muntinlupa 
1 1.8 
City of Las Piñas, City of Muntinlupa 1 1.8 
City of Las Piñas, City of Muntinlupa, 
City of Parañaque, City of Quezon 
1 1.8 
City of Las Piñas, City of Quezon, 
City of Taguig 
1 1.8 
City of Makati, City of Manila, City of 
Pasig, City of San Juan 
1 1.8 
City of Mandaluyong, City of Manila 1 1.8 
City of Manila, City of Marikina, City 
of Quezon, City of San Juan 
1 1.8 
City of Manila, City of Pasig 1 1.8 
City of Manila, City of Quezon 2 3.6 
City of Manila, City of Quezon, City 
of Taguig 
1 1.8 
City of Manila, City of Taguig 1 1.8 
City of Marikina, City of Quezon 1 1.8 
City of Muntinlupa, City of Manila 1 1.8 
City of Quezon, City of Valenzuela 1 1.8 
N=56.  
 
A total of 60 respondents participated in the study. However, 
only 56 respondents were included in the study after screening 
based on the inclusion criteria. Table 1 depicts the 
sociodemographic profile of the respondents in terms of age, 
gender, medical specialization, years of practice, and 
classification and location of hospital. Majority belong to the 
group age ranging from 31 to 45, comprising of three groups 
(31-35, 36-40 and 41-45) with a total frequency of 30 (53%). 
For gender, the respondents were dominated by females (34, 
61%). Three groups of specializations (dermatologists, 
urologists, and otolaryngologists) comprise the majority, with a 
frequency of 12 for each group, summing up to 64% of the total 
respondents. A total of 33 or 59% of the respondents have been 
practicing their profession for less than 15 years. For the 
distribution of the respondents according to the location of the 
hospital employed in, majority of the respondents practice in 
the City of Manila (17, 30%), Quezon City (10, 18%), City of 
Pasig (6, 11%). Lastly, for the distribution of the respondents 
according to classification of the hospital ownership, it was 
shown that most of the physicians practice in private hospitals 
with a frequency of 23 or 41% of the respondents.  
 
  B. Overview of Knowledge, Attitudes, and Practices of 
the Physicians 
 
Table.2. presents the distribution of respondent physicians 
according to the level of knowledge, attitudes, and practices 
regarding P. aeruginosa biofilms, clinical application of its 
detection, and its diagnosis along with the average KAP score. 
 
Table 2. Level of KAP of the Respondent Physicians. 
Level of Knowledge N % 
Good knowledge 46 82.14 
Moderate knowledge 7 12.50 
Poor knowledge 3 5.36 
Level of Attitudes   
Positive attitude 1 1.79 
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Neutral attitude 52 92.86 
Negative attitude 3 5.36 
Level of Practices   
Good practice 9 16.07 
Moderate practice 29 51.79 
Poor practice 18 32.14 
Note. Average knowledge score = 6.30 (Good knowledge), 
average attitude score = 22.93 (Neutral attitude), and average 
practice score = 1.77 (Moderate practice). 
 
It was shown that majority of the respondent physicians have 
good knowledge (46, 82.14%), neutral attitude (52, 92.86%), 
and moderate practices (29, 51.79%). The average score for the 
8-point knowledge assessment was 6.30 points, which was 
interpreted as possessing good knowledge. As for the 35-point 
attitude assessment, the physicians scored an average of 22.93 
points, which was interpreted as having neutral attitude. 
Meanwhile, the average score for the 4-point practices 
assessment was 1.77 points. Moderate practice on P. 
aeruginosa biofilm detection may be due to the absence of 
biofilm detection tests in hospital laboratories in the 
Philippines. 
 
Table.3. presents the ranking of the six medical specialization 
classifications based on their KAP score. A discrepancy in 
knowledge across the medical specialist groups was evident. It 
was likely that the otolaryngologists had the greatest knowledge 
(7.00) because of extensive literature providing evidence that 
several frequently encountered otolaryngological diseases are 
related to biofilms [12]. Conversely, the pulmonologists were 
the least knowledgeable (5.75) possibly due to literature in their 
specialty focusing on cystic fibrosis and ventilator associated 
pneumonia, which occur with much lesser incidence [13].  
 
In dermatology, P. aeruginosa biofilm infections are 
encountered in burn wounds and chronic wounds, with the latter 
having a lifetime prevalence of only 1-2% [14]. The lack of 
exposure may explain for their relatively low level of 
knowledge (5.75). Reconstructive specialists, urologists, 
infectious disease specialists had similar levels of knowledge 
(6.50, 6.33, 6.29). Despite the discrepancy, a satisfactory level 
of knowledge regarding biofilms was observed in all six groups 
of medical specialists.  
 
As for the attitude about biofilm and P. aeruginosa biofilm, the 
pulmonologists ranked first among the six medical specialist 
groups, scoring an average of 24.26. This may be attributed to 
their willingness to utilize biofilm detection test on their 
patients suspected or confirmed with P. aeruginosa infection. 
Three out of the five pulmonologist who participated in the 
study answered that they would test 81-100% of their patients 
if a biofilm detection was available. Reconstructive specialists 
(23.96), infectious disease specialists (23.90), and 
dermatologist (23.61) follow in rank with similar average 
scores. Placing in lower ranks were the otolaryngologists 
(21.93) and urologists (21.43). 
 
For practices, reconstructive specialists have the highest 
practice among the medical specialties (2.38). They have the 
highest practice because they request for a variety of laboratory 
tests such as wound culture or C/S, tissue and swab culture, 




Table.3. Ranking of Medical Specialists Based on their KAP Scores. 
Medical Specialization 
Knowledge Attitudes Practices 




Infectious disease specialist 6.29 4 23.90 3 1.29 6 
Pulmonologist 5.60 6 24.26 1 2.20 2 
Dermatologist 5.75 5 23.61 4 1.83 3 
Reconstructive specialist 6.50 2 23.96 2 2.38 1 
Urologist 6.33 3 21.43 6 1.67 4 
Otolaryngologist 7.00 1 21.93 5 1.50 5 
Note. Perfect scores for each category are 8 for knowledge, 35 for attitudes, and 4 for practices. 
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It was likely that they correlate the laboratory test results to 
assume P. aeruginosa biofilm formation in burn wounds 
infections and chronic wounds. They were followed by 
pulmonologists (2.20), dermatologists (1.83), urologists (1.67), 
and otolaryngologists (1.50). Conversely, infectious disease 
specialists have the lowest practice (1.29) because half of the 
respondents expressed that they do not use laboratory test/s to 
diagnose P. aeruginosa BAI, while the other half only request 
for swab C/S, culture, and C/S. 
 
  C. Knowledge 
 
Table 4 presents the extent of knowledge of the respondent 
physicians about biofilm and P. aeruginosa biofilm. Items were 
ranked according to the number of correct responses. Most 
physicians were knowledgeable that “Biofilms protect the 
microbes from the host immune response.” (55, 98.21%) and 
“Biofilms exhibit increased resistance against antimicrobials 
and antibiotics.” (54, 96.43%). Such understanding of the 
recalcitrant nature of biofilms suggests recognition that 
biofilms are less responsive to standard antimicrobial therapy 
and therefore require the use of less common or novel 
antibiotics and therapeutic strategies [15]. Most physicians 
were knowledgeable regarding biofilm’s ability to hinder 
wound healing (51, 91.07%), cause hospital-acquired infections 
(50, 89.29%), and reform within 24 hours if not completely 
removed (48, 85.71%). Understanding biofilms contribute to 
hospital-acquired infections implies the awareness of biofilm-
related infections caused by medical devices such as catheters, 
ventilators, and implants.  
 
Knowledge that biofilms affect wound healing and tend to 
reform with insufficient removal serves as the rationale in the 
management of chronic wounds in which frequent 
debridement, cleansing, compression, topical application of 
antibiotics, and use of wound dressings that provide a balanced 
moist environment are necessary [9]. Only 37 (66.07%) 
physicians were knowledgeable on the behavioral differences 
between the planktonic and biofilm form of P. aeruginosa. 
Meanwhile, physicians were least aware that  
“Biofilms cover and protect the wound” (35, 62.50%) and that 
“Biofilms produced by P. aeruginosa are difficult to treat 
because the bacteria in them replicate at a much slower rate.” 
(23, 41.07%). Ranking of the questions indicate good 
knowledge of the harm caused by biofilms but a lack in 
comprehension of its mechanism and behavior. 
 
  D. Attitude  
 
As depicted in table 5, the overall attitude of the respondents 
regarding biofilm and P. aeruginosa biofilm was neutral with 
an average weighted mean of 2.57, implying that the 
respondents do not have any negative attitude about biofilm and 
P. aeruginosa biofilm detection. Notably, the questions that 
contributed greatly to this result were items 1 (Mean = 3.39), 6 
(Mean = 2.52), 7 (Mean = 3.32), and 8 (Mean = 2.98). In 
question 1, the physicians were asked if “The presence of P. 
aeruginosa biofilm was easy to detect visually”, in which most 
of them disagreed/strongly disagreed. This implies the absence 
of a tool that could easily detect the biofilms that lead the 
physicians to disagree in the aforementioned statement, which 
was reasonable as there was a lack of practice in routine biofilm 
detection in the Philippines.   
 
As for question 6, the physicians rated the obstacles such as 
uncertainty of using new technology, cost of test, and lack of 
evidence for clinical utility as a moderate obstacle. Some 
physicians also specified in the open-ended question that the 
availability of a biofilm test, or lack thereof, can hinder the 
adoption of a biofilm test in the laboratory setting leading to a 
neutral attitude, which was expected because aside from the 
lack of standardized protocol for the diagnosis of biofilm, the 
materials required for some detection test such as 2,3-bis (2-
methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino) carbonyl 
2H-tetrazolium hydroxide (XTT) were very costly [16]. 
Having presented the possibility of using biofilm detection test 
in the clinical practice in the Philippines as questioned in item 
7, the physicians were questioned on what percent of their 
patients suspected or confirmed of P. aeruginosa infection they 
would test. The physicians’ answers were  
 
Table.4. Extent of Knowledge of the Respondent Physicians about Biofilm and P. aeruginosa Biofilm. 
Questions (True/False/I do not know) Correct Response % Rank 
1. Biofilms cover and protect the wound. 35 62.50 7 
2. The presence of biofilm can be a barrier to wound healing 51 91.07 3 
INTERNATIONAL JOURNAL OF PROGRESSIVE RESEARCH IN SCIENCE AND ENGINEERING, VOL.2, NO.8, AUGUST 2021.  
 
  
NICOLE CHRISTINE B. HOLGADO., ET.AL: KNOWLEDGE, ATTITUDES, AND PRACTICES OF PHYSICIANS IN TERTIARY 
HOSPITALS ON THE CLINICAL APPLICATION OF PSEUDOMONAS AERUGINOSA BIOFILM DETECTION 
367 
 
3. Biofilms do not contribute to nosocomial infection 50 89.29 4 
4. Biofilms produced by P. aeruginosa are difficult to treat because the 
bacteria in them replicate at a much slower rate. 
23 41.07 8 
5. Biofilms can reform within 24 hours, if not fully removed, after disruption 
(e.g. cleansing, debridement). 
48 85.71 5 
6. P. aeruginosa behave the same whether in a biofilm form or not 
(planktonic). 
37 66.07 6 
7. Biofilms protect the microbes from the host immune response. 55 98.21 1 
8. Biofilms exhibit increased resistance against antimicrobials and antibiotics. 54 96.43 2 
Average 44.13 78.79  







1. The presence of P. aeruginosa biofilm was easy to detect visually. 3.39 Neutral 
2. P. aeruginosa biofilms can be present where there are no signs of infection. 2.30 Positive 
3. P. aeruginosa biofilm presence can be inferred by clinical symptoms such as 
antimicrobial therapy failure, delayed healing, and recurrent infections. 
1.88 Positive 
4. If a clinical laboratory test to detect P. aeruginosa biofilms were available, how helpful 
would it be for the patients? 
2.10 Positive 
5. Please rate the level of impact of a biofilm detection test compared with other 




6. Given a certain level of test performance, please rate the obstacles to adoption of a 
biofilm detection test. 
2.52 Neutral 
7. If a test for biofilm detection were available, what percent of your patients suspected 
or confirmed of P. aeruginosa infection would you test? 
3.32 Neutral 
8. Please input any concerns or comments regarding the clinical application of biofilm 
detection tests in the Philippine setting. 
2.98 Neutral 
Average Weighted Mean 2.57 Neutral 
a The weighted mean in each item were interpreted as “Positive” (1 – 2.49), “Neutral” (2.5 – 3.49) and “Negative” (3.5 – 5). 
 
distributed across the following ranges: 81-100% (18), 0-20% 
(12), 61-80% (11), 41-60% (11), 21-40% (8); resulting in an 
overall neutral attitude.  
 
Meanwhile, concerns or comments of the Physicians regarding 
the clinical application of biofilm detection test in the 
Philippines were inquired in item 8 and figure 3 shows the 
distribution of the responses of the physicians per topic. The 
responses of the physicians were categorized to the following 
topics: concerns, suggestions for use, positive outlooks need for 
information and increased awareness, doubts regarding impact, 
and none or N/A. 
 
 
Fig. 3. Concerns or Comments of Physicians regarding the Clinical 
Application of Biofilm Detection Tests in Philippine Setting 
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Concerns regarding biofilm testing were mainly its lack of 
availability, high cost, specimen required and storage 
requirements, and lack of awareness among other physicians. 
Meanwhile, suggestion for the use of biofilm detection were for 
conditions or infections such as atopic dermatitis, delayed 
wound healing, burn patients at risk of developing P. 
aeruginosa burn wound infections, treatment of urosepsis in 
stones, and chronic long standing and/or dormant infections.  
 
As for the positive comments regarding the use of biofilm 
detection test, respondents mentioned that the usage of biofilm 
detection test would be advantageous against the culture 
method, especially in ICU setting, as available methods for the 
presence of biofilms, particularly, the “Clinical BioFilm Ring 
Test” developed by BioFilm Control yields results in two (2) 
hours, faster than obtaining results from culture [17]. 
 
In contrast, doubts regarding the utility of biofilm were based 
on the assumption of the presence of P. aeruginosa biofilms in 
certain medical conditions and the current practice of shifting 
to culture-guided treatment when patients were unresponsive to 
empiric treatment. Having these varied answers resulted in the 
neutral attitude of the physicians regarding the clinical 
application of biofilm detection test. 
 
  E. Practices 
 
Table.6. displays the practices of the respondent physicians 
regarding the detection methods of biofilm and P. aeruginosa 
biofilm and the effects of test results on antimicrobial therapy. 
As gleaned, two items fall on moderate practice, while the other 
two falls under poor practice.  
 
Results of moderate to poor practice were obtained due to the 
absence of biofilm detection tests in Philippine tertiary hospital 
laboratories. Furthermore, physicians have moderate practice in 
response to changing the empiric course of antimicrobial 
therapy based on the biofilm detection test result for P. 
aeruginosa (69.64%) due to the development of antibiotic 
resistance. Antibiotic resistance occurs because the targeted 
bacteria was protected by the biofilm from antibiotics [18]. 
Continuous administration of low dosage of antibiotics may 
promote biofilm formation and establishment of biofilm-
specific  
 
Table 6. Practices of the Respondent Physicians about Biofilm and P. aeruginosa Biofilm. 
Practices % Interpretation a 
1. Do you use laboratory test/s to diagnose P. aeruginosa biofilm-associated infections? 21.43 Poor 
2. Does the hospital laboratory conduct biofilm detection test/s? 8.93 Poor 
3. Assuming that there was no biofilm detection test available, what services offered by the 
hospital laboratory would you request to aid in diagnosing P. aeruginosa biofilm-
associated infections? 
76.79 Moderate 
4. For P. aeruginosa biofilms detected in a patient, would the test result change your empiric 
course of antimicrobial therapy? 
69.64 Moderate 
a The interpretation was based on the percentage of each item. Good practice for 80-100%, moderate practice for 60-79%, and poor practice for 
those less than 60%. 
 
antimicrobial resistance [19]. Additionally, there were 
instances wherein physicians misuse antibiotics due to 
overtreatment as expressed by a respondent.  
 
This indicates that test results detecting P. aeruginosa biofilm 




Fig. 4. Methods used by Physicians to Detect P. aeruginosa Biofilm-
associated Infections. 
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Figure.4. tackles the alternative laboratory services used by 
physicians to detect P. aeruginosa BAI. Due to the absence of 
biofilm detection tests in the Philippines, physicians request 
alternative laboratory services. According to Figure 4, culture 
and sensitivity test (C/S) was the most common laboratory 
service requested by physicians. This was followed by culture, 
gram stain (GS) requested either with culture or C/S studies, 
and C/S requested with other studies. Additionally, there were 
few respondents who answered “none available,” and others 
opting for other practices. It was likely that the combination of 
culture test and sensitivity test to identify the bacteria and 
determine either sensitivity or susceptibility of the identified 
bacteria to antimicrobial drugs makes the C/S preferred by 
physicians. However, C/S was not effective to detect biofilm 
due to separate reasons of culture test and sensitivity test. 
Culture test has low sensitivity rate in detecting growing 
bacteria in biofilm, difficulty in detecting highly diverse 
distribution of biofilms, possibility of false negative results due 
to absence of colony formation from slow-growing bacteria, 
and resistance of biofilm producing bacteria to grow in the 
culture [20][21][22]. Alongside, sensitivity test was not 
effective in the detection of biofilm due to its virulence and 
resistance [23]. On the other hand, GS was quite dubious for 
the detection of biofilm due to interference of biofilm 
polymeric matrix with the stain reagents used and non-specific 
staining of crystal violet to connective tissue and cellular debris 
of burn wound eschar [24]. Furthermore, a respondent 
expressed that the presence of biofilm could be assumed based 
on the results of alternative laboratory services. This indicates 
that there was no standard test or method for the detection of P. 
aeruginosa biofilm. This was mainly due to the absence of the 
laboratory test.  
 
  F. Correlation of Knowledge, Attitudes, and Practices of 
the Physicians 
  
Table.7. Correlation of KAP of the Respondent Physicians regarding 
P. aeruginosa Biofilm, Clinical Application of Biofilm Detection, and 
Diagnosis of P. aeruginosa Biofilm-Associated Infections. 
Variable r P-value 
Knowledge-Attitude .000 .997 
Knowledge-Practice -.130 .340 
Attitude-Practice .230 .089 
α=0.05. N=56. Correlation was significant at 0.05 level (2-tailed). 
Table.7. depicts the results of the Pearson correlation analysis 
between the KAP of the respondent physicians about P. 
aeruginosa biofilm, biofilm detection, and diagnosis. The 
results of Pearson correlation analysis show a failure to reject 
H0, meaning there was no significant relationship between the 
KAP of the respondent physicians. A weak positive correlation 
(r = .230, p = 0.089) exists between attitude-practice, indicating 
that an increase in practice of the diagnosis and treatment of P. 
aeruginosa BAIs may be associated with a slightly more 
positive attitude towards the clinical application of biofilm 
detection. However, it was not statistically significant and, thus, 
has a small chance of increasing positive attitudes. Weak 
negative correlation was found between knowledge-practice (-
.130), but it was also not statistically significant. Considering 
both the weak positive and weak negative correlations for 
attitude-practice and knowledge-practice, increasing the level 
of practice may slightly improve the overall KAP. 
 
  G. The Need for P. aeruginosa Biofilm Detection in 
Philippine Hospitals 
 
P. aeruginosa biofilms pose a major problem in various 
medical fields due to its resistance and tolerance to host 
immune response and antimicrobials. It was reported to be the 
most common cause of nosocomial infections because of its 
adhesion to surfaces of medical devices, implants, and hospital 
environment. In dermatology and reconstructive surgery, 
biofilm was known for its colonization of chronic or severe 
wounds, spongiotic or acantholytic dermatosis, and post-
operative wound infections [25]. In the otolaryngology field, it 
causes chronic ear infections and lung infections in cystic 
fibrosis patients [12]. For urology, it can cause acute prostatitis, 
catheter-associated UTIs, and ureteral stent-associated 
infections [26]. In addition, the presence of P. aeruginosa 
biofilm in BAI often leads to antibiotic therapy failure resulting 
in the emergence of antibiotic resistance [18][19]. Alternative 
laboratory tests requested by physicians were reported to low 
sensitivity rates and possibility of false negatives [20]. In this 
study, the lack of availability of biofilm detection test/s 
conducted in hospital laboratories was apparent in the responses 
of the physicians. The majority of respondents answered that 
they have no idea or that the hospitals have no test for biofilm 
detection. Even the Research Institute for Tropical Medicine 
(RITM), a national reference laboratory in the Philippines, does 
not offer laboratory services for biofilm detection for any 
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bacteria nor for P. aeruginosa. Thus, it reiterates the point that 
there is an absence of biofilm detection test and lack of 
diagnostic practice in the Philippines. 
V. CONCLUSION 
The study shows that majority of the respondents were aged 31 
to 45, female, practicing as dermatologists, otolaryngologists, 
and urologists in private tertiary hospitals based in Manila, 
Quezon City, and Pasig City. Physicians demonstrated good 
knowledge regarding the nature of biofilms and its effect on the 
treatment and management of P. aeruginosa infections but 
lacked knowledge on the mechanism of biofilms. They hold a 
neutral attitude on biofilm detection tests as they were aware of 
the benefits and obstacles involving the clinical 
implementation. Practice in the diagnosis and clinical 
management of P. aeruginosa BAI was moderate. In addition, 
no statistically significant relationship exists between the extent 
of knowledge and attitude of the respondent physicians 
regarding biofilm, P. aeruginosa biofilm, and methods to detect 
P. aeruginosa biofilm. 
 
Due to the unavailability of definitive methods of biofilm 
detection, physicians resort to alternative methods such as 
culture, GS/CS, and C/S. However, due to the unreliability of 
these methods, establishing a standard method for the detection 
of P. aeruginosa biofilm is highly suggested.  
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